Citations 4
P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY
Lin, Yaxiong, Martin, Thomas , Berdeja, J. G., Deol, Abhinav , Htut, Myo, Munshi, Nikhil C. , O’Donnell, Elisabeth K., Jackson, C. C., Yeh, Tzu‐Min, Banerjee, Arnob , Zudaire, Enrique, Pacaud, Lida , Usmani, S. Z., Jakubowiak, Andrzej , Agha, Mounzer , Cohen, Adam D. , Htut, Myo , Lesokhin, Alexander M. , Jackson, C.C., Madduri, Deepu , Zhou, C., Jagannath, Sundar
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 851-852
P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
Weisel, K., Mateos, María‐Victoria , Martin, Thomas , Berdeja, J. G., Lin, Yi , Thilakarathne, Pushpike, Diels, Joris , Haefliger, B., Hague, Clare, Gonzalez, A., Schecter, Jordan M. , Gries, Katharine S. , Strulev, Vadim, Nesheiwat, Tonia, Pacaud, Lida , Einsele, H., Moreau, P., Vincent, Laure , Jakubowiak, Andrzej , Jagannath, Sundar , Ghilotti, Francesca , Moreau, P.
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 861-862
P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
Popat, Rakesh , Badros, Ashraf , Kumar, Seema, Cohen, Alan R., Manier, Salomon , Voorhees, Peter M. , Rifkin, Robert M. , Martin, T., Jeng, Bennie H. , Lee, H, Berdeja, J. G., Jadhav, Vinay, Tosolini, A, Eliason, L, Palumbo, A, Trudel, S., Richardson, PG, Popat, Rakesh , Rodríguez‐Otero, Paula , Gay, Francesca , Chari, Ajai , Weisel, Katja C , Farooq, Asim V. , Chng, Wee Joo , Palumbo, Antonio , Dimopoulos, Meletios Α. , Lonial, Sagar , Terpos, Evangelos
HemaSphere | April 6, 2022 | Volume: 6 | Issue: No issue available | Pages: 18-18
B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Gay, Francesca Maria, Berdeja, J. G., Stefano, V De, Hooper, B, Haltner, A, Kumar, S, Martin, T, Mateos, MV, Moreau, P, Rosta, E, Samjoo, IA, Usmani, S. Z., Weisel, K, Cc, Jackson, Olyslager, Y, Schecter, JM, Vogel, M, Garrett, A, Lee, S, Nesheiwat, T, Pacaud, L, Zhou, C, Valluri, S, Lin, Y, Hari, Parameswaran , Hooper, Becky , Rosta, Emily, Weisel, Katja C , Olyslager, Yunsi, Schecter, JM, Garrett, Ashraf, Lee, S, Nesheiwat, T, Pacaud, Lida , Costa, Luciano J. , Lin, Yi
HemaSphere | April 6, 2022 | Volume: 6 | Issue: No issue available | Pages: 8-8